MedPath
NMPA Approval

Rasburicase for injection

国药准字J20180087

December 3, 2018

S20180024

Drug Information

注射用拉布立海

法舒克

注射剂

1.5mg

生物制品

December 3, 2018

Company Information

Applicant Company

54,rue La Boétie,F-75008 Paris,France

Manufacturing Company

sanofi s.p.a.

Via Valcanello 4, 03012 Anagni (FR), Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.